UFSP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.830000E-01
Normal-vs-Stage2
3.558800E-01
Normal-vs-Stage3
6.325400E-01
Normal-vs-Stage4
4.978000E-01
Stage1-vs-Stage2
1.419970E-01
Stage1-vs-Stage3
5.283400E-01
Stage1-vs-Stage4
4.096200E-01
Stage2-vs-Stage3
9.645400E-01
Stage2-vs-Stage4
6.361700E-02
Stage3-vs-Stage4
3.244400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.776000E-01
Normal-vs-AfricanAmerican
4.876200E-01
Normal-vs-Asian
1.098570E-01
Caucasian-vs-AfricanAmerican
8.230200E-01
Caucasian-vs-Asian
1.206020E-01
AfricanAmerican-vs-Asian
1.423190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.524200E-01
Normal-vs-Female
4.853200E-01
Male-vs-Female
3.821600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.595600E-01
Normal-vs-Age(41-60Yrs)
6.678200E-01
Normal-vs-Age(61-80Yrs)
3.815800E-01
Normal-vs-Age(81-100Yrs)
5.663200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.346400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.425400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.911400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.496100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.212200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.198780E-01
Normal-vs-Daily Drinker
1.572360E-01
Normal-vs-Weekly Drinker
1.473220E-01
Normal-vs-Occasional Drinker
6.193800E-01
Normal-vs-Social Drinker
7.276200E-01
Non Drinker-vs-Daily Drinker
8.563400E-01
Non Drinker-vs-Weekly Drinker
9.931000E-01
Non Drinker-vs-Occasional Drinker
9.429900E-02
Non Drinker-vs-Social Drinker
6.214500E-02
Daily Drinker-vs-Weekly Drinker
8.882800E-01
Daily Drinker-vs-Occasional Drinker
1.619810E-01
Daily Drinker-vs-Social Drinker
1.120210E-01
Weekly Drinker-vs-Occasional Drinker
1.821620E-01
Weekly Drinker-vs-Social Drinker
1.328800E-01
Occasional Drinker-vs-Social Drinker
8.136600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.161240E-01
Normal-vs-Grade 2
8.484600E-03
Normal-vs-Grade 3
4.182300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.182400E-01
Grade 1-vs-Grade 3
8.676000E-01
Grade 1-vs-Grade 4
1.161240E-01
Grade 2-vs-Grade 3
3.978400E-01
Grade 2-vs-Grade 4
8.484600E-03
Grade 3-vs-Grade 4
4.182300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.391800E-01
Normal-vs-NonDiabetic
4.191000E-01
Diabetic-vs-NonDiabetic
6.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.241800E-01
Normal-vs-NoPancreatitis
3.915800E-01
Pancreatitis-vs-NoPancreatitis
8.479800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.855600E-01
Normal-vs-N1
3.886000E-01
N0-vs-N1
2.217200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.129600E-01
Normal-vs-TP53-NonMutant
6.283400E-01
TP53-Mutant-vs-TP53-NonMutant
5.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
